[1]
|
White, D.J. and Vanthuyne, A. (2006) Vulvovaginal Candidiasis. Sexually Transmitted Infections, 82, iv28. http://dx.doi.org/10.1136/sti.2006.023168
|
[2]
|
Hamad, M., Kazandji, N., Awadallah, S. and Allam, H. (2014) Prevalence and Epidemiological Characteristics of Vaginal Candidiasis in the UAE. Mycoses, 57, 184-190.
http://dx.doi.org/10.1111/myc.12141
|
[3]
|
Hong, E., Dixit, S., Fidel, P.L., Bradford, J. and Fischer, G. (2014) Vulvovaginal Candidiasis as a Chronic Disease: Diagnostic Criteria and Definition. Journal of Lower Genital Tract Disease, 18, 31-38. http://dx.doi.org/10.1097/LGT.0b013e318287aced
|
[4]
|
Gunther, L.S., Martins, H.P., Gimenes, F., Abreu, A.L., Consolaro, M.E. and Svidzinski, T.I. (2014) Prevalence of Candida albicans and non-albicans Isolates from Vaginal Secretions: Comparative Evaluation of Colonization, Vaginal Candidiasis and Recurrent Vaginal Candidiasis in Diabetic and non-Diabetic Women. Journal of Medical Microbiology, 63, 1436-1445. http://dx.doi.org/10.1590/1516-3180.2014.1322640
|
[5]
|
Richter, S.S., Galask, R.P., Messer, S.A., Hollis, R.J., Diekema, D.J. and Pfaller, M.A. (2005) Antifungal Susceptibilities of Candida Species Causing Vulvovaginitis and Epidemiology of Recurrent Cases. Journal of Clinical Microbiology, 43, 2155-2162.
http://dx.doi.org/10.1128/JCM.43.5.2155-2162.2005
|
[6]
|
Sobel, J. D. (2007) Vulvovaginal Candidosis. The Lancet, 369, 1961-1971.
http://dx.doi.org/10.1016/S0140-6736(07)60917-9
|
[7]
|
Moreira, D., Auler, M.E., Ruiz, L.S., Silva, E.H., Hahn, R.C. and Paula, C.R. (2014) Species Distribution and Antifungal Susceptibility of Yeasts Isolated from Vaginal Mucosa. Revista de Patologia Tropical, 43, 48-56. http://dx.doi.org/10.5216/rpt.v43i1.29371
|
[8]
|
Sobel, J.D. (2016) Recurrent Vulvovaginal Candidiasis. American Journal of Obstetrics & Gynecology, 214, 15-21. http://dx.doi.org/10.1016/j.ajog.2015.06.067
|
[9]
|
Chew, S.Y. and Than, L.T. (2016) Vulvovaginal Candidosis: Contemporary Challenges and the Future of Prophylactic and Therapeutic Approaches. Mycoses, 59, 262-273.
http://dx.doi.org/10.1111/myc.12455
|
[10]
|
Martins, H.P., da Silva, M.C., Paiva, L.C., Svidzinski, T.I. and Consolaro, M.E. (2012) Efficacy of Fluconazole and Nystatin in the Treatment of Vaginal Candida Species. Acta Dermato-Venereologica, 92, 78-82. http://dx.doi.org/10.2340/00015555-1194
|
[11]
|
Dias, L.B., de Souza Carvalho Melhem, M., Szeszs, M.W., Filho, J.M. and Hahn, R.C. (2011) Vulvovaginal Candidiasis in Mato Grosso, Brazil: Pregnancy Status, Causative Species and Drugs Tests. Brazilian Journal of Microbiology, 42, 1300-1307.
http://dx.doi.org/10.1590/S1517-83822011000400009
|
[12]
|
Fan, S., Liu, X., Wu, C., Xu, L. and Li, J. (2015) Vaginal Nystatin versus Oral Fluconazole for the Treatment for Recurrent Vulvovaginal Candidiasis. Mycopathologia, 179, 95-101.
http://dx.doi.org/10.1007/s11046-014-9827-4
|
[13]
|
Nguyen, Y., Lee, A. and Fischer, G. (2016) Management of Chronic Vulvovaginal Candidiasis: A Long Term Retrospective Study. Australasian Journal of Dermatology.
http://dx.doi.org/10.1111/ajd.12497
|
[14]
|
Lee, S.C., Lo, H.J., Fung, C.P., Lee, N. and See L.C. (2009) Disk Diffusion Test and E-Test with Enriched Mueller-Hinton Agar for Determining Susceptibility of Candida Species to Voriconazole and Fluconazole. Journal of Microbiology, Immunology and Infection, 42, 148-153.
|
[15]
|
Campana, E.H., Carvalhaes, C.G., Barbosa, P.P., Machado, A.M.O., Paula, A.M. and Gales, A.C. (2011) Evaluation of M.I.C.E.TM, Etest and CLSI Broth Microdilution Methods for Antimicrobial Susceptibility Testing of Nosocomial Bacterial Isolates. Jornal Brasileiro de Patologia e Medicina Laboratorial, 47, 157-164.
http://dx.doi.org/10.1590/S1676-24442011000200011
|
[16]
|
Koga-Ito, C.Y., Lyon, J.P. and Resende, M.A. (2008) Comparison between E-Test and CLSI Broth Microdilution Method for Antifungal Susceptibility Testing of Candida albicans Oral Isolates. Revista do Instituto de Medicina Tropical de Sao Paulo, 50, 7-10.
http://dx.doi.org/10.1590/S0036-46652008000100002
|
[17]
|
Madhavan, P., Jamal, F., Chong, P.P. and Ng, K.P. (2010) In Vitro Activity of Fluconazole against Clinical Isolates of Candida spp. by E-Test Method. Tropical Biomedicine, 27, 200-207.
|
[18]
|
Kumar, D., Bhattacharyya, S., Gupta, P., Banerjee, G. and Singh, M. (2015) Comparative Analysis of Disc Diffusion and E-Test with Broth Micro-Dilution for Susceptibility Testing of Clinical Candida Isolates against Amphotericin B, Fluconazole, Voriconazole and Caspofungin. Journal of Clinical and Diagnostic Research, 9, DC01-DC04.
|
[19]
|
Clinical Laboratory Standards Institute (CLSI) (2002) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard Document M27-A2, Wayne, PA.
|
[20]
|
Clinical Laboratory Standards Institute (CLSI) (2008) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard Document M27-S3, Wayne, PA.
|
[21]
|
Clinical Laboratory Standards Institute (CLSI) (2012) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard Document M27-S4, Wayne, PA.
|
[22]
|
Johnson, S.R., Griffiths, H. and Humberstone, F.J. (2010) Attitudes and Experience of Women to Common Vaginal Infections. Journal of Lower Genital Tract Disease, 14, 287-294. http://dx.doi.org/10.1097/LGT.0b013e3181d85bb7
|
[23]
|
Barbedo, L.S. and Sgarbi, D.B.G. (2010) Candidiasis. Jornal Brasileiro de Doencas Sexualmente Transmissíveis, 22, 22-38.
|
[24]
|
Dota, K.F.D., Freitas, A.R., Consolaro, M.E.L. and Svidzinski, T.E.I. (2011) A Challenge For Clinical Laboratories: Detection of Antifungal Resistance in Candida Species Causing Vulvovaginal Candidiasis. Laboratory Medicine, 42, 87-93.
http://dx.doi.org/10.1309/LMDFCA8YEZ0MQULA
|
[25]
|
Cernicka, J. and Subik, J. (2006) Resistance Mechanisms in Fluconazole-Resistant Candida albicans Isolates from Vaginal Candidiasis. International Journal of Antimicrobial Agents, 27, 403-408. http://dx.doi.org/10.1016/j.ijantimicag.2005.12.005
|
[26]
|
Vijaya, D., Dhanalakshmi, T.A. and Kulkarni, S. (2014) Changing Trends of Vulvovaginal Candidiasis. Journal of Laboratory Physicians, 6, 28-30.
http://dx.doi.org/10.4103/0974-2727.129087
|
[27]
|
Tseng, Y.A., Lee, W.T. and Kuo, T.C. (2005) In-Vitro Susceptibility of Fluconazole and Amphotericin B against Candida Isolates from Women with Vaginal Candidiasis in Taiwan. Journal of Food and Drug Analysis, 13, 12-16.
|
[28]
|
Shahid, Z. and Sobel, J.D. (2009) Reduced Fluconazole Susceptibility of Candida albicans Isolates in Women with Recurrent Vulvovaginal Candidiasis: Effects of Long-Term Fluconazole Therapy. Diagnostic Microbiology and Infectious Disease, 64, 354-356.
http://dx.doi.org/10.1016/j.diagmicrobio.2009.03.021
|
[29]
|
Feng, L.J., Wan, Z., Wang, X.H., Li, R.Y. and Liu, W. (2010) Relationship between Antifungal Resistance of Fluconazole Resistant Candida albicans and Mutations in ERG11 Gene. Chinese Medical Journal, 123, 544-548.
|
[30]
|
Burguess, D.S., Hastings, R.W., Summers, K.K., Hardin, T.C. and Rinaldi, M.G. (2000) Pharmacodynamics of Fluconazole, Itraconazole and Amphotericin B against Candida albicans. Diagnostic Microbiology and Infectious Disease, 36, 13-18.
http://dx.doi.org/10.1016/S0732-8893(99)00097-8
|
[31]
|
Deepa, R., Sunil Rao, P. and Kottigade, S. (2014) In-Vitro Susceptibility of Fluconazole Resistant Candidemial Isolates to Mycafungin and Anidulafungin. International Journal of Current Microbiology and Applied Sciences, 3, 424-427.
|
[32]
|
Sanguinetti, M., Posteraro, B. and Lass-Florl, C. (2015) Antifungal Drug Resistance among Candida Species: Mechanisms and Clinical Impact. Mycoses, 58, 2-13.
http://dx.doi.org/10.1111/myc.12330
|
[33]
|
Badiee, P. and Alborzi, A. (2011) Susceptibility of Clinical Candida Species Isolates to Antifungal Agents by E-Test, Southern Iran: A Five Year Study. Iranian Journal of Microbiology, 3, 183-188.
|
[34]
|
Silva, M.G.C., Rodrigues, G.S., Goncalves, I.L. and Grazziotin, N.A. (2015) Distribution of Candida Species and Susceptibility to Fluconazole Isolated from Blood Cultures at the Regional Hospital in Passo Fundo, RS, Brazil. Jornal Brasileiro de Patologia e Medicina Laboratorial, 51, 158-161. http://dx.doi.org/10.5935/1676-2444.20150027
|
[35]
|
Wang, F.J., Zhang, D., Liu, Z.H., Wu, W.X., Bai, H.H. and Dong, H.Y. (2016) Species Distribution and in Vitro Antifungal Susceptibility of Vulvovaginal Candida Isolates in China. Chinese Medical Journal, 129, 1161-1165. http://dx.doi.org/10.4103/0366-6999.181964
|
[36]
|
Shi, X.Y., Yang, Y.P., Zhang, Y., Li, W., Wang, J.D., Huang, W.M., et al. (2015) Molecular Identification and Antifungal Susceptibility of 186 Candida Isolates from Vulvovaginal Candidiasis in Southern China. Journal of Medical Microbiology, 64, 390-393.
http://dx.doi.org/10.1099/jmm.0.000024
|
[37]
|
Antonopoulou, S., Aoun, M., Alexopoulos, E.C., Baka, S., Logothetis, E. and Kalambokas, T. (2009) Fenticonazole Activity Measured by the Methods of the European Committee on Antimicrobial Susceptibility Testing and CLSI against 260 Candida Vulvovaginitis Isolates from Two European Regions and Annotations on the Prevalent Genotypes. Antimicrobial Agents and Chemotherapy, 53, 2181-2184. http://dx.doi.org/10.1128/AAC.01413-08
|
[38]
|
Zhou, X., Westman, R., Hickey, R., Hansmann, M.A., Kennedy, C., Osborn, T.W. and Forney, L.J. (2009) Vaginal Microbiota of Women with Frequent Vulvovaginal Candidiasis. Infection and Immunity, 77, 4130-4135. http://dx.doi.org/10.1128/IAI.00436-09
|
[39]
|
Ou, T.Y., Chang, F.M., Cheng, W.N., Lara, A., Chou, M.L., Lee, W.F., et al. (2016) Fluconazole Induces Rapid High-Frequency MTL Homozygosis with Microbiological Polymorphism in Candida albicans. Journal of Microbiology, Immunology and Infection, in Press.
http://dx.doi.org/10.1016/j.jmii.2015.12.009
|
[40]
|
Torres-Rodriguez, J.M., Madrenys, N., Jimenez, T. and Saballs, P. (2007) Minimal Inhibitory Concentrations of Candida Species to Five Antifungals by Using the Reference Dilution Micro Method and the E-Test. Revista Iberoamericana de Micología, 14, 115-118.
|
[41]
|
Diekema, D.J., Messer, S.A., Boyken, L.B., Hollis, R.J., Kroeger, J., Tendolkar, S., et al. (2009) In Vitro Activity of Seven Systemically Active Antifungal Agents against a Large Global Collection of Rare Candida Species as Determined by CLSI Broth Microdilution Methods. Journal of Clinical Microbiology, 47, 3170-3177.
http://dx.doi.org/10.1128/JCM.00942-09
|
[42]
|
Spampinato, C. and Leonardi, D. (2013) Candida Infections, Causes, Targets, and Resistance Mechanisms: Traditional and Alternative Antifungal Agents. BioMed Research International, 2013, Article ID: 204237. http://dx.doi.org/10.1155/2013/204237
|